A new valve device for severe tricuspid leak
Part of Heart & circulation clinical trials.
This trial tests a new valve device for people with severe leakage of the tricuspid valve. The device is placed inside the heart without open surgery, with the goal of reducing the leak and improving symptoms like shortness of breath and swelling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have severe or worse leakage of the tricuspid valve (the valve on the right side of your heart).
- You should have symptoms like shortness of breath, swelling, or fatigue, or signs that your heart is having trouble pumping blood.
- Your heart anatomy must be suitable for this new valve, checked with imaging tests like CT or ultrasound.
- You must be on the best possible heart medications for your condition.
- You must be willing and able to give your consent and follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called TricValve, which is placed through a catheter (a thin tube) to fix a leaky tricuspid valve on the right side of the heart. It aims to reduce blood flowing backward and improve heart failure symptoms for people who can't have open-heart surgery and haven't been helped by other catheter treatments.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This study tests a new device to fix a leaky tricuspid valve without open-heart surgery. It is for people with severe leakage who are considered too high-risk for traditional surgery.
This trial looks at a catheter-based procedure using the TricValve system for people with severe “tricuspid regurgitation” (a leaky tricuspid valve) who are very symptomatic. It may help reduce the backflow and improve heart function, especially for people who are too unwell for or not helped by standard options.
This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
Hear when a new Symptomatic Tricuspid Regurgitation (TR) Graded as Severe or Greater trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.